These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 3863217

  • 1. Influence of imipenem on the serum resistance of enterobacteriaceae.
    Wiemer CW, Kubens B, Opferkuch W.
    Rev Infect Dis; 1985; 7 Suppl 3():S426-31. PubMed ID: 3863217
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].
    Bompard Y, Lambert T, Gantzer A, Chastel A, Voinnesson A, Aufrant C.
    Pathol Biol (Paris); 1988 May; 36(5):521-4. PubMed ID: 3043351
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The activity of moxalactam against Enterobacteriaceae and anaerobia in vitro].
    Quan JJ, Wang Y, Ji JS, Wang YF, Wang HP, Xu YC, Yu YS.
    Zhonghua Yi Xue Za Zhi; 2016 May 17; 96(18):1459-64. PubMed ID: 27266357
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
    Bartmann K, Tarbuc R.
    Infection; 1982 May 17; 10(6):361-70. PubMed ID: 6818153
    [Abstract] [Full Text] [Related]

  • 10. Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant staphylococci, cefotaxime-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
    Vurma-Rapp U, Kayser FH, Barberis-Maino L.
    J Antimicrob Chemother; 1986 Dec 17; 18 Suppl E():27-33. PubMed ID: 3102452
    [Abstract] [Full Text] [Related]

  • 11. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P, Soussy CJ, Orsoni A, Brickley X, Duval J.
    Pathol Biol (Paris); 1988 May 17; 36(5):425-9. PubMed ID: 3043338
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
    Berche P, Gaillard JL.
    Ann Biol Clin (Paris); 1986 May 17; 44(6):624-7. PubMed ID: 3826779
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients.
    Costopoulos C, Legakis NJ, Papafragas E, Marinis E.
    Chemotherapy; 1984 May 17; 30(3):158-64. PubMed ID: 6610538
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R, Mittermayer H, Feierl G, Allerberger F, Wendelin I, Hirschl A, Reisinger EC.
    Wien Klin Wochenschr; 1999 Jul 30; 111(14):549-54. PubMed ID: 10467641
    [Abstract] [Full Text] [Related]

  • 17. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
    Jarlier V, Bismuth R, Grosset J.
    Pathol Biol (Paris); 1983 May 30; 31(5):336-42. PubMed ID: 6312393
    [Abstract] [Full Text] [Related]

  • 18. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
    Kawakami Y, Okimura Y, Horiuchi N, Kanai M.
    Jpn J Antibiot; 1982 Sep 30; 35(9):2314-7. PubMed ID: 6292543
    [No Abstract] [Full Text] [Related]

  • 19. [In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
    Maugein J, Perrier F, Cony Makhoul P, Fourche J, Darmaillac V.
    Pathol Biol (Paris); 1995 Apr 30; 43(4):253-7. PubMed ID: 7567110
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.